Molecular Pathogenesis of HPV16‐Associated Cervical Cancer: From Viral Entry to Therapeutic Interventions
ChemistrySelect · 2026-01 · 11 (1)
DOI: 10.1002/slct.202505590 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemistrySelect, online erschienen am 03.01.2026. Verfasst von Sunil Kumar und 4 weiteren Autor:innen. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 157 Literaturangaben. Gefördert von: Indian Council of Medical Research.
Abstract (Originalsprache)
Cervical cancer poses significant global health challenge, especially in low‐ and middle‐income countries. It is primarily caused by persistent infection with high‐risk human papillomavirus type 16 (HPV16). Disease progression from early infection to invasive cancer is multistep process driven by virus–host complex molecular interactions. This review presents molecular pathogenesis of HPV16‐driven cervical cancer, focusing on intricate mechanisms from virus entry to malignant transformation. It details the steps involved, from viral attachment on basement membrane to internalization through actin‐dependent endocytic pathway. Following internalization, virus hijacks host mitotic machinery and undergoes series of orchestrated steps to deliver viral genome to host nucleus. This review describes these steps including enzymatic priming by proteases and host chaperones, capsid uncoating endosomal system, L2‐mediated membrane penetration, and subsequent retrograde transport of viral genome‐protein complex to nucleus. It also explores functions of the driving oncogenes E6 and E7, which degrade two crucial tumor suppressor genes, p53 and pRb. The review highlights how constitutive expression of E6/E7, coupled with aneuploidy play key roles in uncontrolled cell division, genomic instability, cellular plasticity, and induction of epithelial–mesenchymal transition to promote cancer stem cell traits. Finally, the review focuses on therapeutic interventions for cervical cancer, including current prophylactic vaccines, screening programs, emerging therapeutic vaccines against E6/E7, small molecule inhibitors to impair viral life cycle, and advanced therapeutic modalities, including gene editing, immunotherapy, and nanotherapeutics. Thus, this review aims to provide researchers and clinicians with updated comprehensive knowledge on HPV16 pathogenesis, oncogenic transformation to cervical cancer, vaccination and therapeutic modalities, to enable the eradication of this disease.
Förderung
- Indian Council of Medical Research
Zitieren
APA
Kumar, S., Yadav, P., Maurya, A., Yadav, S. C., & Prasad, T. (2026). Molecular Pathogenesis of HPV16‐Associated Cervical Cancer: From Viral Entry to Therapeutic Interventions. ChemistrySelect, 11(1). https://doi.org/10.1002/slct.202505590
Vancouver
Kumar S, Yadav P, Maurya A, Yadav SC, Prasad T. Molecular Pathogenesis of HPV16‐Associated Cervical Cancer: From Viral Entry to Therapeutic Interventions. ChemistrySelect. 2026;11(1). doi:10.1002/slct.202505590
BibTeX
@article{Kumar2026,
author = {Kumar, Sunil and Yadav, Pooja and Maurya, Anjali and Yadav, Subhash Chandra and Prasad, Tulika},
title = {Molecular Pathogenesis of HPV16‐Associated Cervical Cancer: From Viral Entry to Therapeutic Interventions},
journal = {ChemistrySelect},
year = {2026},
volume = {11},
number = {1},
doi = {10.1002/slct.202505590}
}
EUVIMED